OSMT Insider Trading Activity and SEC Form 4 Filings
OSMT insider trading summary
No open-market insider purchases or sales of Osmotica Pharmaceuticals plc (OSMT) have been reported on SEC Form 4 in the past 12 months.
Latest OSMT insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Dec 16, 2021 | James Schaub | EVP and COO | Buy | $100K (93,800 @ $1.07) |
| Jan 13, 2020 | David F Burgstahler | Director | Buy | $6.3M (1,250,000 @ $5.00) |
| Jan 13, 2020 | Sriram Venkataraman | Director | Buy | $6.3M (1,250,000 @ $5.00) |
| Jan 13, 2020 | Orbit Co-Invest A-1 LLC | 10% Owner | Buy | $6.3M (1,250,000 @ $5.00) |
| Jan 13, 2020 | Avista Healthcare Partners, L.P. | 10% Owner | Buy | $6.3M (1,250,000 @ $5.00) |
| Jan 13, 2020 | Avista Capital Partners III GP, L.P. | 10% Owner | Buy | $6.3M (1,250,000 @ $5.00) |
| Jan 13, 2020 | Harsaul Foundation | 10% Owner | Buy | $6.3M (1,250,000 @ $5.00) |
| Jan 13, 2020 | Avista Healthcare Partners GP, Ltd. | 10% Owner | Buy | $6.3M (1,250,000 @ $5.00) |
| Jan 13, 2020 | Orbit Co-Invest I LLC | 10% Owner | Buy | $6.3M (1,250,000 @ $5.00) |
| Jan 13, 2020 | Orbit Co-Invest III LLC | 10% Owner | Buy | $6.3M (1,250,000 @ $5.00) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.